The matter was identified as cellulosic fibers and/or plastic. If infused, the matter could trigger both chronic and acute reactions and could potentially be life-threatening, according to a news release.
Baxter received four complaints in six months from customers who saw the particulate matter before administering the solution to a patient, according to the news release.
The pharmaceutical company is recalling three lots of sodium chloride injection and one lot of potassium chloride injection. The lots were distributed worldwide between February 2013 and June 2014.
Baxter is one of the pharmaceutical companies working with the U.S. Food and Drug Administration to help alleviate the saline solution shortage, even temporarily importing solution from its manufacturing facility in Spain.
More Articles on the Saline Shortage:
Navigating the Saline Solution Shortage: 4 Things to Know
FDA Works to Ease National Saline Shortage
Hospitals Running Low on IV Fluid
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
